Literature DB >> 11358283

Neuroprotective effect of acute and chronic administration of copper (II) sulfate against MPP+ neurotoxicity in mice.

M Alcaraz-Zubeldia1, P Rojas, C Boll, C Rios.   

Abstract

Neurodegenerative effects of MPP+, the main metabolite of MPTP include dopamine (DA) depletion and enhanced lipid peroxidation (LPO) in mice striata, both associated to free radicals overproduction. Since copper is related to several antioxidant enzymes, we tested its neuroprotective effect against MPP+-induced neurotoxicity (20 microg/3 microl). CuSO4 pretreatment was administrated by either acute (2.5 mg/kg, i.p.) or chronic (350 or 700 mg/l doses through drinking water, for 30 days) schemes. Acute administration blocked MPP+-induced striatal LPO only when administered 16 or 24 hours before MPP+, and prevented the DA-depleting effect only at 24 hours. Chronic CuSO4 prevented the LPO increase, and blocked the DA depletion only at the higher dose used (700 mg/l). Neuroprotective effect of CuSO4 was dependent on the dose and the time of pretreatment, which suggest that this lag could be related with mechanisms of activation or synthesis of copper-dependent proteins responsible of cellular defense against MPP+.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11358283     DOI: 10.1023/a:1007680616056

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  19 in total

1.  Changes of metallothionein I + II proteins in the brain after 1-methyl-4-phenylpyridinium administration in mice.

Authors:  P Rojas; J Hidalgo; M Ebadi; C Rios
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2000-01       Impact factor: 5.067

2.  Transgenic mice with increased Cu/Zn-superoxide dismutase activity are resistant to N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity.

Authors:  S Przedborski; V Kostic; V Jackson-Lewis; A B Naini; S Simonetti; S Fahn; E Carlson; C J Epstein; J L Cadet
Journal:  J Neurosci       Date:  1992-05       Impact factor: 6.167

3.  Flameless atomic absorption spectrophotometric determination of manganese in rat brain and other tissues.

Authors:  E Bonilla
Journal:  Clin Chem       Date:  1978-03       Impact factor: 8.327

4.  Degeneration of the cerebellar system in X-chromosome-linked copper malabsorption.

Authors:  M Iwata; A Hirano; J H French
Journal:  Ann Neurol       Date:  1979-06       Impact factor: 10.422

5.  Reduced ferroxidase activity in the cerebrospinal fluid from patients with Parkinson's disease.

Authors:  M C Boll; J Sotelo; E Otero; M Alcaraz-Zubeldia; C Rios
Journal:  Neurosci Lett       Date:  1999-04-23       Impact factor: 3.046

6.  Increased striatal lipid peroxidation after intracerebroventricular MPP+ administration to mice.

Authors:  P Rojas; C Rios
Journal:  Pharmacol Toxicol       Date:  1993-06

7.  In vivo lipid peroxidation in rat brain following intracortical Fe2+ injection.

Authors:  W J Triggs; L J Willmore
Journal:  J Neurochem       Date:  1984-04       Impact factor: 5.372

8.  Regional specificity in alterations of rat brain copper and catecholamines following perinatal copper deficiency.

Authors:  J R Prohaska; W R Bailey
Journal:  J Neurochem       Date:  1994-10       Impact factor: 5.372

Review 9.  Copper as an essential nutrient.

Authors:  M Olivares; R Uauy
Journal:  Am J Clin Nutr       Date:  1996-05       Impact factor: 7.045

Review 10.  Copper biochemistry and molecular biology.

Authors:  M C Linder; M Hazegh-Azam
Journal:  Am J Clin Nutr       Date:  1996-05       Impact factor: 7.045

View more
  15 in total

1.  The copper chelator, D-penicillamine, does not attenuate MPTP induced dopamine depletion in mice.

Authors:  M B H Youdim; E Grünblatt; S Mandel
Journal:  J Neural Transm (Vienna)       Date:  2006-06-01       Impact factor: 3.575

2.  Neuroprotective effect of Buddleja cordata methanolic extract in the 1-methyl-4-phenylpyridinium Parkinson's disease rat model.

Authors:  Gabriela Pérez-Barrón; José Guillermo Avila-Acevedo; Ana María García-Bores; Sergio Montes; Sara García-Jiménez; Ismael León-Rivera; Moisés Rubio-Osornio; Antonio Monroy-Noyola
Journal:  J Nat Med       Date:  2014-09-25       Impact factor: 2.343

3.  Escin, a novel triterpene, mitigates chronic MPTP/p-induced dopaminergic toxicity by attenuating mitochondrial dysfunction, oxidative stress, and apoptosis.

Authors:  Govindasamy Pushpavathi Selvakumar; Thamilarasan Manivasagam; Karamkolly R Rekha; Richard L Jayaraj; Namasivayam Elangovan
Journal:  J Mol Neurosci       Date:  2014-05-02       Impact factor: 3.444

4.  Astaxanthin protects against MPTP/MPP+-induced mitochondrial dysfunction and ROS production in vivo and in vitro.

Authors:  Dae-Hee Lee; Cuk-Seong Kim; Yong J Lee
Journal:  Food Chem Toxicol       Date:  2010-11-05       Impact factor: 6.023

5.  Neuroprotective effect of matrine on MPTP-induced Parkinson's disease and on Nrf2 expression.

Authors:  Fanhua Meng; Jianhui Wang; Fuxiang Ding; Yunliang Xie; Yingjie Zhang; Jie Zhu
Journal:  Oncol Lett       Date:  2016-11-14       Impact factor: 2.967

Review 6.  Possible mechanisms of neurodegeneration in schizophrenia.

Authors:  Iván Pérez-Neri; Jesús Ramírez-Bermúdez; Sergio Montes; Camilo Ríos
Journal:  Neurochem Res       Date:  2006-09-28       Impact factor: 3.996

7.  EGb761 blocks MPP+-induced lipid peroxidation in mouse corpus striatum.

Authors:  P Rojas; B Garduño; C Rojas; R M Vigueras; J Rojas-Castañeda; C Rios; N Serrano-Garcia
Journal:  Neurochem Res       Date:  2001-11       Impact factor: 3.996

8.  Protective effects of resveratrol on glutamate-induced damages in murine brain cultures.

Authors:  Rudolf Moldzio; Khaled Radad; Christopher Krewenka; Barbara Kranner; Johanna Catharina Duvigneau; Wolf-Dieter Rausch
Journal:  J Neural Transm (Vienna)       Date:  2013-03-05       Impact factor: 3.575

9.  Mitochondria dysfunction was involved in copper-induced toxicity in MES23.5 cells.

Authors:  Li-Min Shi; Hong Jiang; Jun Wang; Ze-Gang Ma; Jun-Xia Xie
Journal:  Neurosci Bull       Date:  2008-04       Impact factor: 5.203

10.  Free copper, ferroxidase and SOD1 activities, lipid peroxidation and NO(x) content in the CSF. A different marker profile in four neurodegenerative diseases.

Authors:  Marie-Catherine Boll; Mireya Alcaraz-Zubeldia; Sergio Montes; Camilo Rios
Journal:  Neurochem Res       Date:  2008-02-29       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.